A detailed history of Fsc Wealth Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Fsc Wealth Advisors, LLC holds 21,557 shares of PFE stock, worth $552,937. This represents 0.46% of its overall portfolio holdings.

Number of Shares
21,557
Previous 21,549 0.04%
Holding current value
$552,937
Previous $602,000 3.49%
% of portfolio
0.46%
Previous 0.45%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$27.7 - $31.39 $221 - $251
8 Added 0.04%
21,557 $623,000
Q2 2024

Jul 17, 2024

BUY
$25.26 - $29.6 $12,630 - $14,800
500 Added 2.38%
21,549 $602,000
Q1 2024

Apr 16, 2024

SELL
$25.89 - $29.73 $3,987 - $4,578
-154 Reduced 0.73%
21,049 $584,000
Q4 2023

Jan 16, 2024

BUY
$26.13 - $33.94 $6,663 - $8,654
255 Added 1.22%
21,203 $610,000
Q3 2023

Oct 23, 2023

BUY
$32.09 - $37.51 $49,226 - $57,540
1,534 Added 7.9%
20,948 $694,000
Q2 2023

Jul 18, 2023

BUY
$36.12 - $41.79 $37,673 - $43,586
1,043 Added 5.68%
19,414 $712,000
Q1 2023

Apr 18, 2023

BUY
$39.39 - $51.28 $6,381 - $8,307
162 Added 0.89%
18,371 $749,000
Q4 2022

Jan 17, 2023

BUY
$41.75 - $54.5 $124,331 - $162,301
2,978 Added 19.55%
18,209 $0
Q3 2022

Oct 13, 2022

BUY
$43.76 - $53.42 $581,701 - $710,112
13,293 Added 685.91%
15,231 $667,000
Q2 2022

Jul 15, 2022

SELL
$46.53 - $55.17 $19,635 - $23,281
-422 Reduced 17.88%
1,938 $102,000
Q1 2022

May 09, 2022

SELL
$45.75 - $56.69 $1,555 - $1,927
-34 Reduced 1.42%
2,360 $122,000
Q4 2021

Apr 28, 2022

BUY
$41.32 - $61.25 $98,920 - $146,632
2,394 New
2,394 $141,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $144B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Fsc Wealth Advisors, LLC Portfolio

Follow Fsc Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fsc Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fsc Wealth Advisors, LLC with notifications on news.